by Team Small News | Dec 4, 2025 | Lupin, Pharma
The pharmaceutical company, Lupin, is reportedly in discussions to acquire Vitabiotics, a UK-based vitamins and supplements manufacturer, in a deal estimated to be worth £1 billion (approximately Rs 11,800 crore). Vitabiotics is a family-owned brand, founded by the... by Team Small News | Nov 28, 2025 | Lupin, Pharma
The Golden Cross is a technical indicator that suggests a trend reversal from bearish to bullish, occurring when the 50-day moving average (DMA) moves above the 200 DMA. For Lupin, a pharmaceutical company, this event may mark the beginning of a recovery phase after a... by Team Small News | Nov 15, 2025 | Lupin, Pharma
Lupin Limited, a global pharmaceutical company, has achieved a significant milestone by securing an S&P Global ESG Score of 91 for 2025. This score places the company among a select group of pharmaceutical organizations that have crossed the 90-point threshold,... by Team Small News | Nov 10, 2025 | Lupin, Pharma
Lupin, a leading pharmaceutical company, has unveiled its ambitious product pipeline and strategic targets, showcasing its commitment to driving growth and innovation in the industry. The company has outlined a robust pipeline of new products and formulations, aimed... by Team Small News | Nov 8, 2025 | Lupin, Pharma
The Lupin Bioresearch Center, a prominent research facility, has achieved a significant milestone by receiving zero observations from the United States Food and Drug Administration (USFDA) following a successful inspection and assessment. This impressive feat...
by Team Small News | Nov 1, 2025 | Apollo Hospital, Aurobindo Pharma, Lupin, Pharma, Sun Pharma
The Indian corporate sector has reported earnings in line with expectations for the September quarter, boosting market sentiment. Several prominent companies, including Indian Oil Corporation, Adani Green Energy, and Hindustan Petroleum Corporation Limited, have...